Pro-Pharmaceuticals, Inc. (AMEX: PRW) announces updates regarding the company's proposed rights offering, pre-New Drug Application (NDA) filing and related meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE